Showing results (11-20 of 152) with videos related to
Sort By:
Pageof 16
Digestion|August 7, 2004
Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University HospitalJulia Seiderer, Burkhard Göke, Thomas OchsenkühnInflammatory Bowel Diseases|November 23, 2006
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective studyJulia Seiderer, Stephan Brand, Karin A Herrmann, et al.Inflammatory Bowel Diseases|June 24, 2005
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's diseaseStephan Brand, Tanja Staudinger, Fabian Schnitzler, et al.Scandinavian Journal of Gastroenterology|November 15, 2006
Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosisJulia Seiderer, Fabian Schnitzler, Stephan Brand, et al.Plos One|January 14, 2012
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's diseaseJürgen Glas, Julia Seiderer, Corinna Bayrle, et al.Pharmacoepidemiology and Drug Safety|May 3, 2014
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodiesFlorian Beigel, Anni Steinborn, Fabian Schnitzler, et al.Plos One|February 1, 2013
IRGM variants and susceptibility to inflammatory bowel disease in the German populationJürgen Glas, Julia Seiderer, Stephanie Bues, et al.Inflammatory Bowel Diseases|December 20, 2007
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBDJulia Seiderer, Ira Elben, Julia Diegelmann, et al.Clinical Immunology (Orlando, Fla.)|February 6, 2008
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel diseaseJulia Seiderer, Julia Dambacher, Dorothea Leistner, et al.Inflammatory Bowel Diseases|January 9, 2007
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's diseaseJulia Dambacher, Tanja Staudinger, Julia Seiderer, et al.Pageof 16